-
1دورية أكاديمية
المؤلفون: Paola Queirolo, Beatrice Dozin, Anna Morabito, Barbara Banelli, Patrizia Piccioli, Cristiana Fava, Claudio Leo, Roberta Carosio, Stefania Laurent, Vincenzo Fontana, Pier Francesco Ferrucci, Chiara Martinoli, Emilia Cocorocchio, Angelo Battaglia, Paolo A. Ascierto, Mariaelena Capone, Ester Simeone, Federica De Galitiis, Elena Pagani, Gian Carlo Antonini Cappellini, Paolo Marchetti, Michele Guida, Stefania Tommasi, Mario Mandalà, Barbara Merelli, Pietro Quaglino, Paolo Fava, Massimo Guidoboni, Massimo Romani, Francesco Spagnolo, Maria Pia Pistillo
المصدر: Frontiers in Immunology, Vol 9 (2018)
مصطلحات موضوعية: CTLA-4 variants, melanoma, ipilimumab, best overall response, overall survival, predictive/prognostic factor, Immunologic diseases. Allergy, RC581-607
وصف الملف: electronic resource
-
2دورية أكاديمية
المؤلفون: Paola Queirolo, Beatrice Dozin, Anna Morabito, Barbara Banelli, Patrizia Piccioli, Cristiana Fava, Claudio Leo, Roberta Carosio, Stefania Laurent, Vincenzo Fontana, Pier Francesco Ferrucci, Chiara Martinoli, Emilia Cocorocchio, Angelo Battaglia, Paolo A. Ascierto, Mariaelena Capone, Ester Simeone, Federica De Galitiis, Elena Pagani, Gian Carlo Antonini Cappellini, Paolo Marchetti, Michele Guida, Stefania Tommasi, Mario Mandalà, Barbara Merelli, Pietro Quaglino, Paolo Fava, Massimo Guidoboni, Massimo Romani, Francesco Spagnolo, Maria Pia Pistillo
المصدر: Frontiers in Immunology, Vol 8 (2017)
مصطلحات موضوعية: CTLA-4 variants, melanoma, ipilimumab, best overall response, overall survival, predictive/prognostic factor, Immunologic diseases. Allergy, RC581-607
وصف الملف: electronic resource
-
3
المؤلفون: Queirolo, P., Dozin, B., Morabito, A., Banelli, B., Piccioli, P., Fava, C., Leo, C., Carosio, R., Laurent, S., Fontana, V., Ferrucci, P. F., Martinoli, C., Cocorocchio, E., Battaglia, A., Ascierto, P. A., Capone, M., Simeone, E., De Galitiis, F., Pagani, E., Cappellini, G. C. A., Marchetti, P., Guida, M., Tommasi, S., Mandala, M., Merelli, B., Quaglino, P., Fava, P., Guidoboni, M., Romani, M., Spagnolo, F., Pistillo, M. P.
مصطلحات موضوعية: Best overall response, CTLA-4 variants, Ipilimumab, Melanoma, Overall survival, Predictive/prognostic factor
URL الوصول: https://explore.openaire.eu/search/publication?articleId=od_______970::a80a4da44e455349e591c4e567ded3d6
https://hdl.handle.net/2318/1890637 -
4دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
5دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
6دورية أكاديمية
المؤلفون: Queirolo P; Department of Medical Oncology, IRCCS AOU San Martino-IST-Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy., Dozin B; Unit of Clinical Epidemiology, IRCCS AOU San Martino-IST-Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy., Morabito A; Unit of Tumor Epigenetics, IRCCS AOU San Martino-IST-Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy., Banelli B; Unit of Tumor Epigenetics, IRCCS AOU San Martino-IST-Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy.; Department of Health Sciences, University of Genova, Genova, Italy., Piccioli P; Unit of Cellular Biology, IRCCS AOU San Martino-IST-Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy., Fava C; Department of Medical Oncology, IRCCS AOU San Martino-IST-Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy., Leo C; Department of Medical Oncology, IRCCS AOU San Martino-IST-Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy., Carosio R; Unit of Tumor Epigenetics, IRCCS AOU San Martino-IST-Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy., Laurent S; Intergruppo Melanoma Italiano (IMI) and Department of Internal Medicine, University of Genova, Genova, Italy., Fontana V; Unit of Clinical Epidemiology, IRCCS AOU San Martino-IST-Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy., Ferrucci PF; Oncology of Melanoma Unit, European Institute of Oncology, Milan, Italy., Martinoli C; Oncology of Melanoma Unit, European Institute of Oncology, Milan, Italy., Cocorocchio E; Oncology of Melanoma Unit, European Institute of Oncology, Milan, Italy., Battaglia A; Oncology of Melanoma Unit, European Institute of Oncology, Milan, Italy., Ascierto PA; Melanoma, Cancer Immunotherapy and Innovative Therapy Unit, Istituto Nazionale Tumori Fondazione 'G. Pascale', Naples, Italy., Capone M; Melanoma, Cancer Immunotherapy and Innovative Therapy Unit, Istituto Nazionale Tumori Fondazione 'G. Pascale', Naples, Italy., Simeone E; Melanoma, Cancer Immunotherapy and Innovative Therapy Unit, Istituto Nazionale Tumori Fondazione 'G. Pascale', Naples, Italy., De Galitiis F; Istituto Dermopatico dell'Immacolata IDI-IRCCS, Rome, Italy., Pagani E; Istituto Dermopatico dell'Immacolata IDI-IRCCS, Rome, Italy., Antonini Cappellini GC; Istituto Dermopatico dell'Immacolata IDI-IRCCS, Rome, Italy., Marchetti P; Istituto Dermopatico dell'Immacolata IDI-IRCCS, Rome, Italy.; Medical Oncology, Sant'Andrea Hospital, Sapienza University of Rome, Rome, Italy., Guida M; Department of Medical Oncology, Molecular Genetics Laboratory, IRCCS Istituto Tumori 'Giovanni Paolo II,'Bari, Italy., Tommasi S; Department of Medical Oncology, Molecular Genetics Laboratory, IRCCS Istituto Tumori 'Giovanni Paolo II,'Bari, Italy., Mandalà M; Unit of Medical Oncology, Department of Oncology and Hematology, Papa Giovanni XXIII Hospital, Bergamo, Italy., Merelli B; Unit of Medical Oncology, Department of Oncology and Hematology, Papa Giovanni XXIII Hospital, Bergamo, Italy., Quaglino P; Dermatologic Clinic, Department of Medical Sciences, University of Turin, Turin, Italy., Fava P; Dermatologic Clinic, Department of Medical Sciences, University of Turin, Turin, Italy., Guidoboni M; Immunotherapy and Cell Therapy, IRCCS-IRST, Meldola, Italy., Romani M; Unit of Tumor Epigenetics, IRCCS AOU San Martino-IST-Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy., Spagnolo F; Department of Medical Oncology, IRCCS AOU San Martino-IST-Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy., Pistillo MP; Unit of Tumor Epigenetics, IRCCS AOU San Martino-IST-Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy.
المصدر: Frontiers in immunology [Front Immunol] 2018 Mar 02; Vol. 9, pp. 403. Date of Electronic Publication: 2018 Mar 02 (Print Publication: 2018).
نوع المنشور: Journal Article; Published Erratum
بيانات الدورية: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Print ISSN: 1664-3224 (Print) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: PubMed not MEDLINE